NCT06861088 2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3 Recruiting
Clinical Trials
8 trialsNCT05625932 2025-08-22
PROTINCOL
Galician Research Group on Digestive Tumors
Phase 3 Completed
NCT05178628 2022-03-29
imPaCT-PRO
Institute of Molecular Medicine and Biomedical Research
Phase 3 Unknown
NCT00423683 2016-06-08
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism
Northwell Health
Phase 3 Terminated
NCT00031837 2015-10-14
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
Phase 3 Terminated
NCT00662688 2013-03-13
PAM07
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Terminated
NCT00951574 2012-02-01
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Phase 3 Completed
NCT00519805 2011-08-08
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown